Assessing the natural course of diabetic retinopathy: A population-based study in Kinmen, Taiwan

Ophthalmic Epidemiology

Volumn 13, Issue 5, 2006, Pages 327-333

  Tung, Tao Hsin ^a,b   Chen, Shih Jen ^a,c   Shih, Hui Chuan ^d   Chou, Pesus ^a   Li, An Fei ^c   Shyong, Mong Ping ^c   Lee, Feng Li ^c   Liu, Jorn Hon ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

Community based study; Diabetic retinopathy; Markov model; Natural course; Screening study; Taiwan; Type 2 diabetes mellitus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLINDNESS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MYDRIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPE; POPULATION RESEARCH; PRIORITY JOURNAL; SCREENING; TAIWAN;

AGED; COMMUNITY HEALTH SERVICES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FUNDUS OCULI; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; OPHTHALMOSCOPY; REPRODUCIBILITY OF RESULTS; TAIWAN;

EID: 33750314126     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580600826637     Document Type: Article

References (25)

1. Garg SK, Marshall G, Chase HP, et al. The use of the Markov process in describing the natural course of diabetic retinopathy. Arch Ophthalmol. 1990;108(9):1245-1247.
2. Diabetic Retinopathy Study Research Group. Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy Study Research Group. Invest Ophthalmol Vis Sci. 1981;21(1 Pt 2):1-226.
3. Early Treatment Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema. ETDRS report number 1. Arch Ophthalmol. 1985;103(12):1796-1806.
4. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. DRVS Report No. 2. Arch Ophthalmol. 1985;103(11):1644-1652.
5. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes. 1986;35(5):530-545.
6. Liu WJ, Yen MF, Tung TH, et al. Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan. Diabet Med. 2003;20(9):727-733.
7. Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. J Am Med Assoc. 2000;283(7):889-896.
8. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(1 Pt 2):164-169.
9. Dasbach EJ, Fryback DG, Newcomb PA, Klein R, Klein BE. Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care. 1991;29(1):20-39.
10. Tung TH, Liu JH, Lee FL, et al. Population-based study of nonproliferative diabetic retinopathy among type 2 diabetic patients in Kinmen, Taiwan. Jpn J Ophthalmol. 2006;50(1):44-52.
11. Tung TH, Chen SJ, Liu JH, et al. A community-based follow-up study on diabetic retinopathy among type 2 diabetics in Kinmen. Eur J Epidemiol. 2005;20(4):317-323.
12. Tung TH, Chen SJ, Lee FL, et al. A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract. 2005;68(3):265-273.
13. Chou P, Liao MJ, Kuo HS, et al. A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care. 1994;17(9):1055-1058.
14. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
15. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report No. 9. Ophthalmology. 1991;98(Suppl 5):766-785.
16. Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677-1682.
17. Kalbfleisch D, Lawless JF. The analysis of panel data under a Markov assumption. J Am Stat Assoc. 1985;80:863-871.
18. Chen THH, Kuo HS, Yen MF, et al. Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics. 2000;56(1):167-172.
19. Kuo HS, Chang HJ, Chou P, Teng L, Chen THH. A Markov chain model to assess the efficacy of screening for non-insulin-dependent diabetes mellitus. Int J Epidemiol. 1999;28(2):233-240.
20. Aiello LP, Gardner TW, King GL, et al. Diabetes retinopathy. Diabetes Care. 1998;21(1):143-156.
21. Hirsch IB. Surveillance for complications of diabetes: don't wait for symptoms before intervening. Postgrad Med. 1996;99(3):147-55, 159-162.
22. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol. 1989;107(2):244-249.
23. British Diabetic Association. Guidelines on the Management of Diabetes in Primary Care. London: British Diabetic Association, 1994.
24. Clinical Standards Advisory Group. Standard of Clinical Care for People with Diabetes. London: HMSO, 1994.
25. Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care. 1997;20(5):725-734.